DRAMMATIC
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 746 by
Mercy Hospital Fort Smith
Fort Smith, AR
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Illinois CancerCare (Bloomington)
Bloomington, IL
- Accepting patients
- Show Principal Investigator
Loyola Center for Health at Burr Ridge
Burr Ridge, IL
- Accepting patients
- Show Principal Investigator
Illinois CancerCare (Canton)
Canton, IL
- Accepting patients
- Show Principal Investigator
Memorial Hospital of Carbondale
Carbondale, IL
- Accepting patients
- Show Principal Investigator
SIH Cancer Institute
Carterville, IL
- Accepting patients
- Show Principal Investigator
Illinois CancerCare (Carthage)
Carthage, IL
- Accepting patients
- Show Principal Investigator
Centralia Oncology Clinic
Centralia, IL
- Accepting patients
- Show Principal Investigator
615 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.